- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 612
TwinStrand completes series A sequence
Alexandria Venture Investments has helped UW's genetic sequencing technology developer TwinStand raise series A financing.
Jan 10, 2020TwinStrand completes $16m series A sequence
Existing investor Alexandria Venture Investments has helped genetic sequencing technology developer TwinStand increase its overall funding to $21.5m.
Jan 10, 2020Soul Machines personifies $40m series B
University of Auckland Inventors Fund has contributed to a $40m series B round for AI-based avatar developer Soul Machines, with the investment led by Temasek.
Jan 10, 2020Daily deal net: January 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jan 9, 2020Quibi cribs another $400m
The bite-sized video streaming platform, which counts a host of corporates among its investors, has revealed $400m in funding along with its launch date.
Jan 9, 2020Virtual Incision sews up $20m
The colectomy-focused robotic surgical device developer has now assembled $51.7m having spun out from University of Nebraska Medical Center in 2006.
Jan 9, 2020VectivBio begins with $35m
Inserm Transfer Initiative featured in the first round for VectivBio, a short bowel syndrome treatment developer spun out of Therachon following the latter's acquisition by Pfizer.
Jan 9, 2020ClassPass clinches $285m series E
The GV-backed fitness and wellness subscription service secured a unicorn valuation in a round that lifted its overall funding to $540m.
Jan 9, 2020Tiger Global buys into Byju's with $200m
The educational app developer, which counts Tencent, Naspers and BCC among its investors, raised the money at a valuation of about $8bn.
Jan 9, 2020VectivBio selects Novo for $35m round
Novo took part in the first round for VectivBio, a short bowel syndrome treatment developer launched out of genetic disease drug developer Therachon.
Jan 9, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


